BOSTON – Cancer patients, brace yourselves. Many new drug treatments cost nearly $100,000 a year, sparking fresh debate about how much a few months more of life is worth.
The latest is Provenge, a first-of-a-kind therapy approved in April. It costs $93,000 a year and adds four months' survival, on average, for men with incurable prostate tumors. Bob Svensson is honest about why he got it: insurance paid.
"I would not spend that money," because the benefit doesn't seem worth it, says Svensson, 80, a former corporate finance officer from Bedford, Mass.
Answer by Rnurse at 7:47 PM on Sep. 27, 2010
Answer by Carpy at 10:08 PM on Sep. 26, 2010
Answer by veronicamw at 10:11 PM on Sep. 26, 2010
Answer by LoriKeet at 11:03 PM on Sep. 26, 2010
Answer by lovinangels at 10:40 PM on Sep. 26, 2010
Answer by yourspecialkid at 10:49 PM on Sep. 26, 2010
Answer by pinkdena at 10:07 PM on Sep. 26, 2010
I am not sure. I think the Pharma companies are able to produce them for cheaper but choose not too.....
As drugs are mass produced this can be the case, but it isn't always the case. However, this also has a lot to do with it:
Part of why it costs so much is that it's not a pill cranked out in a lab, but a treatment that is individually prepared, using each patient's cells and a protein found on most prostate cancer cells. It is expensive and time-consuming to make.
Answer by QuinnMae at 10:18 PM on Sep. 26, 2010
Of course there are plenty of things to live for. I wouldn't want to miss any of the important milestones that my children reach, whether it's 8th grade graduation, Prom, College graduation, weddings, or giving birth to their children. I don't know how to determine what is worth it. This, of course, is going to be a huge issue going forth (moreso than it is now). All of the baby boomers retiring and with an aging population will come a higher cost of medical care. I have no idea how this is going to work since the medical expenses alone will be outrageous.
Answer by QuinnMae at 10:24 PM on Sep. 26, 2010
Answer by grlygrlz2 at 11:19 PM on Sep. 26, 2010